How does gabapentin work in the brain
Pro Research Analysisby 
Searched over 200M research papers
Mechanism of Action of Gabapentin in the Brain
Gabapentin and Voltage-Dependent Calcium Channels (VD-CCs)
Gabapentin, a widely used anticonvulsant and analgesic, primarily exerts its effects by interacting with voltage-dependent calcium channels (VD-CCs). It binds with high affinity to the alpha2delta subunit of these channels, which is crucial for its pharmacological action Taylor1998Van Hooft2002Stefani1998. This binding inhibits calcium influx into neurons, thereby reducing the release of excitatory neurotransmitters such as glutamate Van Hooft2002Stefani1998. This inhibition is particularly significant in presynaptic terminals, where gabapentin attenuates synaptic transmission by reducing calcium currents Van Hooft2002Stefani1998.
Interaction with GABA(B) Receptors
Gabapentin also activates gamma-aminobutyric acid type B (GABA(B)) receptors, which are negatively coupled to VD-CCs. This activation further inhibits calcium influx and neurotransmitter release Bertrand2001Parker2004. The effect of gabapentin on GABA(B) receptors is similar to that of the GABA(B) agonist baclofen, and it is blocked by GABA(B) antagonists, indicating a specific interaction with these receptors Bertrand2001Parker2004.
Modulation of GABA and Glutamate Levels
Gabapentin has been shown to increase the concentration and synthesis rate of GABA in the brain, which may enhance non-vesicular GABA release during seizures Taylor1998Taylor1997Cai2012. This increase in GABA levels contributes to its anticonvulsant and anxiolytic properties. Additionally, gabapentin affects glutamate synthesis by inhibiting the enzyme branched-chain amino acid aminotransferase (BCAA-t), which may help prevent neuronal death in neurodegenerative conditions Taylor1998Taylor1997Leach1997.
Effects on GABA(A) Receptors
Gabapentin enhances the expression of delta subunit-containing GABA(A) receptors (δGABA(A) receptors), which generate tonic inhibitory conductance in neurons . This increased expression likely contributes to the drug's GABAergic effects, such as ataxia and anxiolysis, observed in animal models .
Neurotransmitter Release Inhibition
Gabapentin reduces the release of several monoamine neurotransmitters, including serotonin, which may be relevant to its neurobehavioral actions Taylor1998Taylor1997. This reduction in neurotransmitter release is another mechanism by which gabapentin exerts its therapeutic effects, particularly in conditions involving hyperexcitability and pain.
Conclusion
Gabapentin's multifaceted mechanism of action involves the inhibition of VD-CCs, activation of GABA(B) receptors, modulation of GABA and glutamate levels, and enhancement of δGABA(A) receptor expression. These combined actions contribute to its efficacy in treating epilepsy, neuropathic pain, and other neurological conditions. Understanding these mechanisms provides insight into the broad therapeutic applications of gabapentin and its potential for treating various disorders involving neuronal excitability.
Sources and full results
Most relevant research papers on this topic